Gelonghui November 26th丨Lepu Biopharmaceutical-B (02157.HK) announced that on November 26, 2024, the company entered into a CDMO service framework agreement with lepu medical technology, under which the company and/or its subsidiaries agree to provide CDMO technical services and related supporting equipment to lepu medical technology and/or its subsidiaries.
乐普生物-B(02157.HK)与乐普医疗订立CDMO服务框架协议
Lepu Biotechnology-B(02157.HK) and Lepu Medical Technology have signed a CDMO service framework agreement.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated